AI vs double reading for breast cancer screening
Part of Cancer, Skin clinical trials.
This study compares a single radiologist reading your mammogram with help from artificial intelligence (AI) to the standard method of two radiologists reading it. The goal is to see if AI-assisted reading is just as good at finding cancer while saving time and resources.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 69 years old.
- You are a woman who has never had symptoms of breast disease.
- You are taking part in a regular breast cancer screening program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
This trial compares standard mammograms with mammograms aided by artificial intelligence (AI) to see if AI helps find breast cancer more accurately and reduces unnecessary callbacks. If you're 18 or older and getting a routine screening mammogram at one of the six participating health systems, you may be eligible.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This study tests whether artificial intelligence (AI) can help radiologists read mammograms (breast X-rays) more accurately during routine breast cancer screening. It aims to see if AI can catch more cancers early while reducing unnecessary follow-up exams.
This study tests whether an artificial intelligence (AI) system can help a second reader interpret routine breast screening mammograms. It may improve how consistently images are assessed, especially when the first reader calls them normal or benign.
This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.
Hear when a new Breast Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.